Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient ; day:12 ; month:1 ; year:2021 ; pages:1-2
Annals of hematology ; (12.1.2021), 1-2
- Creator
-
Schlaweck, Sebastian
Brossart, Peter
Heine, Annkristin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-021-04403-4
- URN
-
urn:nbn:de:101:1-2021030520502559541613
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schlaweck, Sebastian
- Brossart, Peter
- Heine, Annkristin
- SpringerLink (Online service)
Other Objects (12)
Bloodless tandem autologous transplant in Jehovah’s Witness patients
A Jehovah's Witness Patient with Polytrauma: Deontology, Law, and Faith
Treatment of Jehovah’s witness patients. Surgical and medico-legal considerations
Skin changes in hairy cell leukemia
Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports
Giant Coronary Aneurysm with Coronary-Pulmonary Artery Fistula in a Jehovah's Witness
Hairy cell leukemia expresses programmed death-1
Thirty years a Watch Tower slave : the confessions of a converted Jehovah's Witness
Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year Experience
Hairy Cell Leukemia: Where Are We in 2023?
Targeting MEK in vemurafenib-resistant hairy cell leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Bloodless tandem autologous transplant in Jehovah’s Witness patients
A Jehovah's Witness Patient with Polytrauma: Deontology, Law, and Faith
Treatment of Jehovah’s witness patients. Surgical and medico-legal considerations
Skin changes in hairy cell leukemia
Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports
Giant Coronary Aneurysm with Coronary-Pulmonary Artery Fistula in a Jehovah's Witness
Hairy cell leukemia expresses programmed death-1
Thirty years a Watch Tower slave : the confessions of a converted Jehovah's Witness
Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year Experience
Hairy Cell Leukemia: Where Are We in 2023?
Targeting MEK in vemurafenib-resistant hairy cell leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Bloodless tandem autologous transplant in Jehovah’s Witness patients
A Jehovah's Witness Patient with Polytrauma: Deontology, Law, and Faith
Treatment of Jehovah’s witness patients. Surgical and medico-legal considerations
Skin changes in hairy cell leukemia
Jehovah’s Witness patients presenting with ruptured ectopic pregnancies: two case reports
Giant Coronary Aneurysm with Coronary-Pulmonary Artery Fistula in a Jehovah's Witness
Hairy cell leukemia expresses programmed death-1
Thirty years a Watch Tower slave : the confessions of a converted Jehovah's Witness
Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year Experience
Hairy Cell Leukemia: Where Are We in 2023?
Targeting MEK in vemurafenib-resistant hairy cell leukemia